Steven Urbach President Chardan Capital Markets, LLC 17 State Street Suite 1600 New York, NY 10004 Tel: 646 465 9003 Fax: 646 465 9091 February 3, 2017Myos Rens Technology Inc. • February 7th, 2017 • Pharmaceutical preparations • New York
Company FiledFebruary 7th, 2017 Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between MYOS Corporation (the “Company”) and Chardan Capital Markets, LLC (“Chardan”) that Chardan shall serve as the exclusive placement agent (the “Services”) for the Company, on a reasonable best efforts basis, in connection with the proposed offer and placement (the “Offering”) by the Company of securities of the Company (the “Securities”). The terms of the Offering and the Securities shall be mutually agreed upon by the Company and the investors and nothing herein implies that Chardan would have the power or authority to bind the Company or an obligation for the Company to issue any Securities or complete the Offering. The Company expressly acknowledges and agrees that the execution of this Agreement does not constitute a commitment by Chardan to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of Chardan with respect to securing any other financing o
Steven Urbach Chardan Capital Markets, LLC Chief Executive Officer 17 State Street Suite 1600 New York, NY 10004 Tel: 646 465 9002 Fax: 646 465 9091Cogint, Inc. • November 23rd, 2016 • Services-advertising • New York
Company FiledNovember 23rd, 2016 Industry Jurisdiction
Jonas Grossman Head of Capital Markets Chardan Capital Markets, LLC 17 State Street Suite 1600 New York, NY 10004 Tel: 646 465 9002 Fax: 646 465 9091IDI, Inc. • May 18th, 2016 • Services-advertising • New York
Company FiledMay 18th, 2016 Industry Jurisdiction
Steven Urbach President Chardan Capital Markets, LLC 17 State Street Suite 1600 New York, NY 10004 Tel: 646 465 9003 Fax: 646 465 9091IDI, Inc. • July 28th, 2015 • Services-advertising • New York
Company FiledJuly 28th, 2015 Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between IDI, Inc. (the “Company”) and Chardan Capital Markets, LLC (“Chardan”) that Chardan shall serve as the exclusive placement agent (the “Services”) for the Company, on a reasonable best efforts basis, in connection with the proposed offer and placement (the “Offering”) by the Company of securities of the Company (the “Securities”). The terms of the Offering and the Securities shall be mutually agreed upon by the Company and the investors and nothing herein implies that Chardan would have the power or authority to bind the Company or an obligation for the Company to issue any Securities or complete the Offering. The Company expressly acknowledges and agrees that the execution of this Agreement does not constitute a commitment by Chardan to purchase the Securities and does not ensure the successful placement of the Securities or any portion thereof or the success of Chardan with respect to securing any other financing on behal